Association of anti-tumor necrosis factor therapy with mortality among veterans with inflammatory bowel disease

9Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Importance: Inflammatory bowel disease (IBD) is commonly treated with corticosteroids and anti-tumor necrosis factor (TNF) drugs; however, medications have well-described adverse effects. Prior work suggests that anti-TNF therapy may reduce all-cause mortality compared with prolonged corticosteroid use among Medicare and Medicaid beneficiaries with IBD. Objective: To examine the association between use of anti-TNF or corticosteroids and all-cause mortality in a national cohort of veterans with IBD. Design, Setting, and Participants: This cohort study used a well-established Veteran's Health Administration cohort of 2997 patients with IBD treated with prolonged corticosteroids (≥3000-mg prednisone equivalent and/or ≥600 mg of budesonide within a 12-month period) and/or new anti-TNF therapy from January 1, 2006, to October 1, 2015. Data were analyzed between July 1, 2019, and December 31, 2020. Exposures: Use of corticosteroids or anti-TNF. Main Outcomes and Measures: The primary end point was all-cause mortality as defined by the Veterans Health Administration vital status file. Marginal structural modeling was used to compare associations between anti-TNF therapy or corticosteroid use and all-cause mortality. Results: A total of 2997 patients (2725 men [90.9%]; mean [SD] age, 50.0 [17.4] years) were included in the final analysis, 1734 (57.9%) with Crohn disease (CD) and 1263 (42.1%) with ulcerative colitis (UC). All-cause mortality was 8.5% (n = 256) over a mean (SD) of 3.9 (2.3) years' follow-up. At cohort entry, 1836 patients were new anti-TNF therapy users, and 1161 were prolonged corticosteroid users. Anti-TNF therapy use was associated with a lower likelihood of mortality for CD (odds ratio [OR], 0.54; 95% CI, 0.31-0.93) but not for UC (OR, 0.33; 95% CI, 0.10-1.10). In a sensitivity analysis adjusting prolonged corticosteroid users to include patients receiving corticosteroids within 90 to 270 days after initiation of anti-TNF therapy, the OR for UC was statistically significant, at 0.33 (95% CI, 0.13-0.84), and the OR for CD was 0.55 (95% CI, 0.33-0.92). Conclusions and Relevance: This study suggests that anti-TNF therapy may be associated with reduced mortality compared with long-term corticosteroid use among veterans with CD, and potentially among those with UC..

References Powered by Scopus

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

4533Citations
N/AReaders
Get full text

Marginal structural models and causal inference in epidemiology

4084Citations
N/AReaders
Get full text

Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial

3922Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn’s colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling

18Citations
N/AReaders
Get full text

Role of digital health and artificial intelligence in inflammatory bowel disease: A scoping review

11Citations
N/AReaders
Get full text

Integrating Evidence to Guide Use of Biologics and Small Molecules for Inflammatory Bowel Diseases

8Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Cohen-Mekelburg, S., Wallace, B. I., Van, T., Wiitala, W. L., Govani, S. M., Burns, J., … Waljee, A. K. (2021). Association of anti-tumor necrosis factor therapy with mortality among veterans with inflammatory bowel disease. JAMA Network Open, 4(3). https://doi.org/10.1001/jamanetworkopen.2021.0313

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Professor / Associate Prof. 2

33%

Researcher 1

17%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Environmental Science 1

20%

Sports and Recreations 1

20%

Psychology 1

20%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 2

Save time finding and organizing research with Mendeley

Sign up for free